Regulatory News
Tuesday, November 29, 2016
BRIEF-Eiger updates progress in clinical development program
* Eiger updates progress in clinical development program for
exendin 9-39 to treat post-bariatric hypoglycemia (pbh)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment